Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid

被引：0
|
作者：
Irja Lutsar
Ian R. Friedland
机构：
[1] Pfizer Global Research & Development Ltd,Sandwich Laboratories
[2] Merck & Co. Inc.,Merck Research Laboratories
来源：
Clinical Pharmacokinetics | 2000年 / 39卷
关键词：
Meningitis; Cephalosporin; Ceftriaxone; Cefotaxime; Bacterial Meningitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Largely because of their low lipophilicity, cephalosporins poorly penetrate through the blood-brain barrier, achieving relatively low cerebrospinal fluid (CSF) concentrations. However, the minimum bactericidal concentrations (MBCs) of the extended spectrum cephalosporins for common meningeal pathogens are generally low; thus, therapeutic CSF drug concentrations several-fold greater than the MBC can be achieved with currently recommended dosage regimens. However, the effectiveness of cephalosporin therapy is unreliable in patients with meningitis caused by highly penicillin-resistant pneumococci.
引用
收藏
页码：335 / 343
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetics and pharmacodynamics of cephalosporins in cerebrospinal fluid
    Lutsar, I
    Friedland, IR
    CLINICAL PHARMACOKINETICS, 2000, 39 (05) : 335 - 343
  • [2] Pharmacokinetics and pharmacodynamics of biapenem in human cerebrospinal fluid
    Ikawa, Kazuro
    Morikawa, Norifumi
    Ikeda, Kayo
    Katagiri, Masaya
    Kiya, Katsuzo
    Isobe, Naoyuki
    Mizoue, Tatsuya
    Kondo, Hiroshi
    Takano, Motoki
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (02) : 184 - 185
  • [3] The Pharmacokinetics and Pharmacodynamics of Meropenem in the Cerebrospinal Fluid of Neurosurgical Patients
    Tsumura, R.
    Ikawa, K.
    Morikawa, N.
    Ikeda, K.
    Shibukawa, M.
    Iida, K.
    Kurisu, K.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (05) : 615 - 621
  • [4] Cerebrospinal fluid pharmacokinetics and pharmacodynamics of intrathecal neostigmine methylsulfate in humans
    Shafer, SL
    Eisenach, JC
    Hood, DD
    Tong, CY
    ANESTHESIOLOGY, 1998, 89 (05) : 1074 - 1088
  • [5] Antibiotic pharmacodynamics in cerebrospinal fluid
    Lutsar, I
    McCracken, GH
    Friedland, IR
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) : 1117 - 1127
  • [6] Pharmacokinetics and pharmacodynamics of oral cephalosporins as critical factors in choice of antibiotics
    Novelli, A
    Fallani, S
    Cassetta, MI
    Conti, S
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (04) : 501 - 505
  • [7] PENETRATION OF NEWER CEPHALOSPORINS INTO CEREBROSPINAL-FLUID
    CHERUBIN, CE
    ENG, RHK
    NORRBY, R
    MODAI, J
    HUMBERT, G
    OVERTURF, G
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 (04): : 526 - 548
  • [8] Influence of lipophilicity on the diffusion of cephalosporins into the cerebrospinal fluid
    Radouane, A
    Pehourcq, F
    Tramu, G
    Creppy, EE
    Bannwarth, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1996, 10 (03) : 309 - 313
  • [9] Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid
    Guglielmo, BJ
    Kostiuk, KA
    Pons, VG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (03) : 437 - 438
  • [10] NEW REGIMENS FOR ADMINISTRATION OF CEPHALOSPORINS AND AMINOGLYCOSIDES - RELATION BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS
    KAMNEV, YV
    ANTIBIOTIKI I KHIMIOTERAPIYA, 1992, 37 (02) : 44 - 50
12345